{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:33:30Z","timestamp":1780914810206,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Boston Children's Hospital Faculty Research Grant"},{"name":"Milton Foundation"},{"DOI":"10.13039\/100013479","name":"Bay Area Lyme Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.diagmicrobio.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T20:24:59Z","timestamp":1544214299000},"page":"160-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Higher C6 enzyme immunoassay index values correlate with a diagnosis of noncutaneous Lyme disease"],"prefix":"10.1016","volume":"94","author":[{"given":"Lise E.","family":"Nigrovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Lipsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia R.","family":"Molins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Wormser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris C.","family":"Garro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Levas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Balamuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Lingampalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Branda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1067\/mem.2003.299","article-title":"Identifying febrile young infants with bacteremia: is the peripheral white blood cell count an accurate screen?","volume":"42","author":"Bonsu","year":"2003","journal-title":"Ann Emerg Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/cir464","article-title":"Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay","volume":"53","author":"Branda","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/cit235","article-title":"Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe","volume":"57","author":"Branda","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2018.12.001_bb5000","doi-asserted-by":"crossref","first-page":"1133-9","DOI":"10.1093\/cid\/cix943","article-title":"Advances in Serodiagnostic Testing for Lyme Disease Are at Hand","volume":"66","author":"Branda","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"31","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0020","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease","volume":"44","author":"Centers for Disease Control and Prevention (CDC)","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.12.001_bb9000","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1542\/peds.2011-1215","article-title":"Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis","volume":"129","author":"Cohn","year":"2012","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3810","article-title":"Hip Synovial Fluid Cell Counts in Children From a Lyme Disease Endemic Area","volume":"141","author":"Dart","year":"2018","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0030","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1542\/peds.2012-2531","article-title":"Distinguishing Lyme from septic knee monoarthritis in Lyme disease-endemic areas","volume":"131","author":"Deanehan","year":"2013","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ttbdis.2015.06.005","article-title":"Epidemiology of Lyme disease in low-incidence states","volume":"6","author":"Forrester","year":"2015","journal-title":"Ticks Tick Borne Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0040","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.annemergmed.2017.08.039","article-title":"Managing peripheral facial palsy","volume":"71","author":"Garro","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0055","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/lary.26273","article-title":"Steroid use in Lyme disease\u2013associated facial palsy is associated with worse long-term outcomes","volume":"127","author":"Jowett","year":"2017","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/0022-1317-49-10-911","article-title":"False-negative serology in patients with neuroborreliosis and the value of employing of different borrelial strains in serological assays","volume":"49","author":"Kaiser","year":"2000","journal-title":"J Med Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320 years after active Lyme disease","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191725","article-title":"Human Borrelia miyamotoi infection in California: serodiagnosis is complicated by multiple endemic Borrelia species","volume":"13","author":"Krause","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2018.12.001_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpeds.2016.04.004","article-title":"False positive Lyme disease IgM immunoblots in children","volume":"174","author":"Lantos","year":"2016","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0080","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/ciw427","article-title":"Evaluation of the C6 Lyme enzyme immunoassay for the diagnosis of Lyme disease in children and adolescents","volume":"63","author":"Lipsett","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0085","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/INF.0000000000000858","article-title":"The positive predictive value of Lyme ELISA for the diagnosis of Lyme disease in children","volume":"34","author":"Lipsett","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.idc.2015.02.005","article-title":"Laboratory diagnosis of Lyme disease: advances and challenges","volume":"29","author":"Marques","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0095","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/cid\/civ185","article-title":"Development of a metabolic biosignature for detection of early Lyme disease","volume":"60","author":"Molins","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.12.001_bb0100","first-page":"3755","article-title":"Collection and characterization of samples for establishment of a serum repository for Lyme disease diagnostic test development and evaluation","volume":"52(10)","author":"Molins","year":"2014"},{"key":"10.1016\/j.diagmicrobio.2018.12.001_bb0105","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/cid\/cix1023","article-title":"Seroreactivity to the C6 peptide in Borrelia Miyamotoi infections occurring in the northeastern United States","volume":"66","author":"Molloy","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1975","article-title":"Accuracy of clinician suspicion of Lyme disease in the emergency department","volume":"140","author":"Nigrovic","year":"2017","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0115","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1469-0691.2011.03749.x","article-title":"High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice","volume":"18","author":"Seriburi","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0125","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1128\/JCM.01853-13","article-title":"Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of Lyme disease with noncutaneous manifestations","volume":"51","author":"Wormser","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","article-title":"Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease","volume":"75","author":"Wormser","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00430-013-0315-0","article-title":"Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa","volume":"203","author":"Wormser","year":"2014","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.12.001_bb0140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ttbdis.2017.12.014","article-title":"Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre","volume":"9","author":"Zwerink","year":"2018","journal-title":"Ticks Tick Borne Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318307193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318307193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T05:42:51Z","timestamp":1565242971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318307193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0732889318307193"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.12.001","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher C6 enzyme immunoassay index values correlate with a diagnosis of noncutaneous Lyme disease","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}